Log in to save to my catalogue

GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signalin...

GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signalin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2021224657

GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats

About this item

Full title

GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats

Publisher

Athens: Spandidos Publications UK Ltd

Journal title

International journal of molecular medicine, 2018-05, Vol.41 (5), p.2977-2985

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications UK Ltd

More information

Scope and Contents

Contents

The present study aimed to investigate the mechanism of glucagon-like peptide-1 receptor (GLP-1R) agonists in the progression of diabetic peripheral neuropathy (DPN) in streptozotocin (STZ)-induced diabetic rats, through inflammatory signaling pathways. The DPN rat model was generated by intraperitoneal injection of STZ and then treated with the GL...

Alternative Titles

Full title

GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2021224657

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2021224657

Other Identifiers

ISSN

1107-3756

E-ISSN

1791-244X

DOI

10.3892/ijmm.2018.3509

How to access this item